DE602004026164D1 - Ultraschallkontrastmittel - Google Patents

Ultraschallkontrastmittel

Info

Publication number
DE602004026164D1
DE602004026164D1 DE602004026164T DE602004026164T DE602004026164D1 DE 602004026164 D1 DE602004026164 D1 DE 602004026164D1 DE 602004026164 T DE602004026164 T DE 602004026164T DE 602004026164 T DE602004026164 T DE 602004026164T DE 602004026164 D1 DE602004026164 D1 DE 602004026164D1
Authority
DE
Germany
Prior art keywords
microparticles
vial
dry powder
body weight
perfluorocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004026164T
Other languages
English (en)
Inventor
Richard Walovitch
Howard Bernstein
Donald E Chickering Iii
Julie Straub
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Acusphere Inc
Original Assignee
Acusphere Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acusphere Inc filed Critical Acusphere Inc
Publication of DE602004026164D1 publication Critical patent/DE602004026164D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE602004026164T 2004-06-04 2004-06-15 Ultraschallkontrastmittel Expired - Lifetime DE602004026164D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1781304A 2004-06-04 2004-06-04

Publications (1)

Publication Number Publication Date
DE602004026164D1 true DE602004026164D1 (de) 2010-05-06

Family

ID=34925364

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026164T Expired - Lifetime DE602004026164D1 (de) 2004-06-04 2004-06-15 Ultraschallkontrastmittel

Country Status (10)

Country Link
EP (1) EP1609483B1 (de)
AT (1) ATE461712T1 (de)
CY (1) CY1110151T1 (de)
DE (1) DE602004026164D1 (de)
DK (1) DK1609483T3 (de)
ES (1) ES2340677T3 (de)
HK (1) HK1086474A1 (de)
PL (1) PL1609483T3 (de)
PT (1) PT1609483E (de)
SI (1) SI1609483T1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5976501A (en) * 1996-06-07 1999-11-02 Molecular Biosystems, Inc. Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6045777A (en) * 1997-06-30 2000-04-04 Acusphere, Inc. Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases

Also Published As

Publication number Publication date
DK1609483T3 (da) 2010-05-31
EP1609483A1 (de) 2005-12-28
PL1609483T3 (pl) 2010-08-31
PT1609483E (pt) 2010-05-06
ES2340677T3 (es) 2010-06-08
EP1609483B1 (de) 2010-03-24
SI1609483T1 (sl) 2010-06-30
ATE461712T1 (de) 2010-04-15
CY1110151T1 (el) 2015-01-14
HK1086474A1 (en) 2006-09-22

Similar Documents

Publication Publication Date Title
Wang et al. Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis
CN104662007B (zh) 胱硫醚‑γ‑裂合酶(CSE)抑制剂
JP2018529762A (ja) 異常炎症反応に関連する状態を処置するための方法および組成物
Yennan et al. Effects of aquatic exercise and land-based exercise on postural sway in elderly with knee osteoarthritis
CO6311066A2 (es) Composiciones de alta densidad que contienen posaconazol y formulaciones que comprenden las mismas
CN106572993A (zh) 用于治疗癌症的组合疗法
EA200101206A1 (ru) Применение биоразлагаемых микросфер, высвобождающих противораковый агент, для лечения глиобластомы
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
TW202128610A (zh) 醫藥調配物
TW202200121A (zh) 治療方法
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
AU2019208238A1 (en) Therapeutic Modifiers of the Reverse Mode of ATP Synthase
CN107982217B (zh) 一种包载疏水性药物的具靶向和放疗增敏双重功能脂质-聚合物、其制备方法及其应用
DE602004013993D1 (de) R für biologische wirksubstanz zur oralen verabreichung
JP2009506043A5 (de)
WO2011137317A1 (en) Methods and compositions for protecting against neurotoxic agents
BRPI0418879A (pt) formulação de dosagem por agente de constrate pelo ultra-som
BR0015149A (pt) Método e composições para administração de taxanos oralmente a pacientes humanos
CN101426490B (zh) 包含α-酮戊二酸/盐的组合物及其用于调节肌肉性能的用途
CN1265786C (zh) 式ⅰ的化合物和紫杉醇在制备用于治疗癌症疾病的药物中的用途
RU2008126108A (ru) Фармацевтическая композиция для лечения остеоартрита, содержащая клодроновую кислоту и гиалуроновую кислоту
DE602004026164D1 (de) Ultraschallkontrastmittel
RU2011139015A (ru) Вызываемая медикаментозными средствами липоатрофия для косметических целей
McMaster et al. Blood Pressure Lowering Effect of Methylmethacrylate Monomer: Potentiation by Blood Volume Deficit.
CN110575551A (zh) 一种超声造影剂及其制备方法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition